// App-Quantinova.ai

4067 : Individual patient data meta-analysis of neoadjuvant chemotherapy followed by surgery versus upfront surgery in esophageal or gastro-esophageal carcinoma.

Researchers

Presenter

  • Matthieu Faron

Principal Investigators

  • Matthew Guy Nankivell

  • Kathryn A. Winter

  • Simon Law

  • Ate Van Der van der Gaast

  • Marc Ychou

  • Murielle Mauer

  • Michele Valmasoni

  • Jack A. Roth

  • Pierre Blanchard

  • Pierre Guillame Thirion

  • Jayne F. Tierney

  • Val Gebski

  • Bryan H. Burmeister

  • Xavier Paoletti

  • Hong Yang

  • Johanna W. van Sandick

  • Michel Ducreux

  • Stefan Michiels

Medical Centers

  • Gustave Roussy Cancer Campus, Villejuif, France

  • Kings College London, London, United Kingdom

  • Statistical Center, Radiation Therapy Oncology Group, Philadelphia, PA, Hong Kong University, Hong Kong

  • China

  • Erasmus MC, Rotterdam, Netherlands

  • IRCM, Institut de Recherche en Cancerologie de Montpellier, INSERM U1194, Universite de Montpellier, Institut Regional du Cancer de Montpellier, Montpellier, France

  • an Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium

  • Padova University Hospital, DIMED, Padova, Italy

  • Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Gustave Roussy, Villejuif, France

  • Saint James's Hospital, Dublin, Ireland

  • MRC Clinical Trials Unit, UCL, London, United Kingdom

  • NHMRC Clinical Trials Centre, The University of Sydney, Sydney, Australia

  • Princess Alexandra Hospital/University of Queensland, Woolloongabba, Australia

  • Institut Curie, Paris Cedex, France

  • Sun Yat-Sen University Cancer Center, Guangdzhou, Guangdong, China

  • Antoni van Leeuwenhoek - NKI (Netherlands Cancer Institute), Amsterdam, Netherlands

  • Gustave Roussy Cancer Campus, Villejuif, France

Locations

  • France

  • United Kingdom

  • Hong Kong

  • China

  • Netherlands

  • Belgium

  • Italy

  • Ireland

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Esophageal Cancer

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A